ArticleCureus2024
A Case of Hyperammonemia Not Attributable to Liver Disease and Treated With IV Ammonia Scavengers.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hyperammonemia is a serious metabolic condition marked by elevated ammonia levels in the blood, leading to neurological damage and systemic complications if untreated. While often associated with liver dysfunction, inborn metabolic errors such as fatty acid oxidation defects, pyruvate metabolism disorders, urea cycle disorders (UCDs), urea splitting bacterial infections, hemato-oncological disorders, and portosystemic shunts are less commonly recognized but significant causes, particularly outside neonatal populations. These metabolic errors, due to partial enzyme deficiencies, may present later in life with atypical symptoms. We report an acute presentation of a female patient in her late fifties with a background of noncirrhotic hyperammonemia of unknown etiology, controlled with oral sodium benzoate. She presented with ataxia, altered mental status, and delusion. The laboratory evaluation revealed significantly elevated ammonia levels, which did not respond to an increased dose of oral sodium benzoate, and she required intravenous ammonia scavengers to achieve acceptable levels. We further discuss several investigations done to establish a cause for her hyperammonemia and a psychiatric diagnosis of erotomania/de Clerambault's syndrome secondary to recurrent hyperammonemia. Although her biochemical workup had some features suggestive of type 2 citrulline deficiency, SLC25A13 mutation analysis for citrin deficiency and an extended R98 panel were negative. Thus, highlighting the complexity of diagnosis of inborn metabolic errors and treatment of metabolic hyperammonemia in the absence of an established diagnosis. It also emphasizes the need for heightened awareness and prompt treatment of inborn metabolic errors in adult patients, following the British Inherited Metabolic Disease Group (BIMDG) management guidelines to prevent severe neurological outcomes. Multidisciplinary management, including liaison with specialists in metabolics, gastroenterology, and dietetics, is crucial for optimizing patient care and outcomes in such complex cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.